NCT03739918

Brief Summary

Benign complex cystic and vascular adrenal tumors comprise a group of lesions characterized by significant rarity. But, their detection is increasing due to improved radiologic imaging techniques. Nevertheless, they are still conflicting with other lesions. the investigators reviewed their experience with complex cystic benign adrenal tumors in adults, review previous reports to determine the appropriate diagnosis and management of these tumors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
291

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 14, 2018

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

3 months

First QC Date

November 8, 2018

Last Update Submit

November 9, 2018

Conditions

Urologic DiseasesAdrenal Tumor

Keywords

CysticAdrenalIncidentalomaVascularBenign

Outcome Measures

Primary Outcomes (1)

  • Number of patients with rare pathologies and correlation with demographic and radiological data

    collection of rare pathologies ,correlation with other review of literature

    7 years

Study Arms (1)

patients with adrenal masses

patients with adrenal mass managed by adrenalectomy

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

291 cases diagnosed with adrenal tumors were treated. Demographic criteria of studied cases and different types of pathologies identified . Three cases were diagnosed to have rare cystic and vascular histopathological variant including: cavernous haemangioma, capillary haemangioma and adrenal teratoma.

You may qualify if:

  • cases with adrenal tumors above 18 years old with rare histopathology

You may not qualify if:

  • age less than 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology and Nephrology Center

Al Mansurah, Aldakahlia, 35516, Egypt

Location

MeSH Terms

Conditions

Urologic DiseasesAdrenal Gland Neoplasms

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsAdrenal Gland DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 14, 2018

Study Start

February 28, 2018

Primary Completion

May 30, 2018

Study Completion

June 30, 2018

Last Updated

November 14, 2018

Record last verified: 2018-11

Locations

EG(1)